Evotec SE (EVO) EBT Margin (2009 - 2025)
Evotec SE (EVO) reported EBT Margin of 34208.36% for Q4 2025, up 5340416.0% on a YoY basis from N/an in Q4 2024, and down 130400.58% sequentially from 26.21% in Q3 2025.
Evotec SE (EVO) EBT Margin (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 9 years of EBT Margin data on file, last reported at 34208.36% in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin rose 5340416.0% year-over-year to 34208.36%; the trailing twelve-month figure through Dec 2025 stood at 33272.38% (down 1027278.0% YoY), and the FY2025 full-year result was 11.01%, up 2433838297.0% from the prior year.
- EBT Margin declined to 34208.36% in Q4 2025, from 26.21% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 54929.35% in Q4 2021 to a low of 87612.52% in Q4 2024.
- A 5-year average of 7389.9% and a median of 14.13% in 2022 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin plunged 8509885 bps in 2022 and jumped 5340416 bps in 2025, its largest moves.
- Tracing EVO's EBT Margin over 5 years: stood at 54929.35% in 2021, then tumbled by 155 bps to 30169.5% in 2022, then jumped by 54 bps to 13882.89% in 2023, then tumbled by 531 bps to 87612.52% in 2024, then jumped by 61 bps to 34208.36% in 2025.
- Business Quant data shows EVO's EBT Margin at 34208.36% in Q4 2025, 26.21% in Q3 2025, and 87612.52% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -34,208.36% |
| Sep 30, 2025 | -26.21% |
| Dec 31, 2024 | -87,612.52% |
| Sep 30, 2024 | -25.35% |
| Dec 31, 2023 | -13,882.89% |
| Sep 30, 2023 | 15.24% |
| Jun 30, 2023 | -9.57% |
| Dec 31, 2022 | -30,169.50% |
| Sep 30, 2022 | 24.94% |
| Jun 30, 2022 | -14.13% |
| Mar 31, 2022 | -41.74% |
| Dec 31, 2021 | 54,929.35% |
| Sep 30, 2021 | 87.93% |
| Jun 30, 2021 | 43.40% |
| Mar 31, 2021 | 40.91% |
| Dec 31, 2020 | 7,164.17% |
| Dec 31, 2019 | 12.70% |
| Sep 30, 2010 | 6.20% |
| Jun 30, 2010 | 12.36% |
| Mar 31, 2010 | 0.00% |